M&C Reacts

Oct 06, 2023

It's the Circle of Life

By Gareth Williams

Could circular RNA be the Next Big Thing for RNA therapeutics? The molecules are much more persistent than linear RNA (such as the mRNA...

Oct 02, 2023

By Gareth Williams

I'm always a sucker for a cephalopod-linked story, so naturally I clicked on this one. Researchers have taken inspiration from the arms...

Sep 07, 2023

By Graham Burnett-Hall

In a boost to UK research that will be welcomed, not just by scientists based in the United Kingdom, but by research groups across...

Sep 05, 2023

By Nicholas Fischer

The new framework was first floated back in January 2023, as a way for the MHRA to streamline the authorisation process by taking...

May 30, 2023

By Lara Sibley

A really interesting article highlighting the potential of AI for drug discovery. The article describes how an AI model was used to...

Apr 27, 2023

By Nicholas Fischer

As part of a sweeping package of proposals concerning Standard Essential Patents, Compulsory Licensing and Supplementary Protection...

Mar 03, 2023

By Susan Bradley

As recently reported in Design Week, London-based product development company Morrama are working on a menopause management app called...

Feb 17, 2023

By M&C Newsroom

We are delighted to see M&C Managing Associate Nick Fischer cited in Endpoints News this week discussing the recent announcement from the...

Jan 25, 2023

By Nicholas Fischer

The European Commission Decision Reliance Procedure (the "Reliance Procedure") was introduced after Brexit as a way of ensuring patients...

Nov 25, 2022

By Paul Chapman

I am aware of some of the controversies surrounding the use of vaccines, but I am an advocate of vaccine use and have filed a great many...

Nov 22, 2022

By Megan Rannard

The Pharmaceutical Security Institute (PSI) is set to launch a new initiative in May 2023 - the E-commerce Alliance for a Socially...